Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Camparo

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2016
Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma RiskZeina Chakhtoura, Fatima Laki, Marie Bernadet, et al.
Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
Pathology|December 18, 2019
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be gradedHemamali Samaratunga, Brett Delahunt, Lars Egevad, et al.
Annals of Diagnostic Pathology|September 30, 2014
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologistsKenneth A Iczkowski, Lars Egevad, Jun Ma, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2016
Gain-of-function Prolactin Receptor Variants Are Not Associated With Breast Cancer and Multiple Fibroadenoma RiskZeina Chakhtoura, Fatima Laki, Marie Bernadet, et al.
Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
Pathology|December 18, 2019
Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be gradedHemamali Samaratunga, Brett Delahunt, Lars Egevad, et al.
Annals of Diagnostic Pathology|September 30, 2014
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologistsKenneth A Iczkowski, Lars Egevad, Jun Ma, et al.
Pageof 9